Skip to content

EBIT at other companies

Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
-$5.23M+6.8%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$39.62M-21.1%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-$19.71M+3.5%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Merck & Co. logo
Merck & Co.MRK
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+30.5%
Enterprise value$1.15B
P/S6,014.3×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Calculated from Ethos Technologies, Inc. ’s reported figures.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's EBIT?
Ethos Technologies, Inc. (LIFE) reported EBIT of -$11.44M in Q1 2026.
How has Ethos Technologies, Inc. 's EBIT changed year-over-year?
Ethos Technologies, Inc. 's EBIT increased by 27.5% year-over-year, from -$15.77M to -$11.44M.
What is the long-term trend for Ethos Technologies, Inc. 's EBIT?
Over 4 years (2021 to 2025), Ethos Technologies, Inc. 's EBIT has grown at a 22.9% compound annual growth rate (CAGR), from -$34.02M to -$77.63M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.